Cargando…
TGF-β1 of no avail as prognostic marker in lyme disease
Background. Within the present in vivo study using the wild type mouse strains C3H/HeN and FVB/N it was intended to (1) measure TGF-β1 expression in the course of lyme disease, (2) examine the potential correlation of TGF-β1 expression with the clinical outcome of a Borrelia infection (with a focus...
Autor principal: | Schumann, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045338/ https://www.ncbi.nlm.nih.gov/pubmed/24918028 http://dx.doi.org/10.7717/peerj.398 |
Ejemplares similares
-
Robust B Cell Responses Predict Rapid Resolution of Lyme Disease
por: Blum, Lisa K., et al.
Publicado: (2018) -
Molecular Evolution of Transforming Growth Factor-β (TGF-β) Gene Family and the Functional Characterization of Lamprey TGF-β2
por: Liu, Siqi, et al.
Publicado: (2022) -
Editorial: TGF-β and T cell biology
por: Soudja, Saïdi, et al.
Publicado: (2023) -
Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders
por: Shive, Carey L., et al.
Publicado: (2021) -
Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack
por: Kraiczy, Peter
Publicado: (2016)